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The involvement of CXCR4 and CCR5 coreceptors in apoptosis induced by the HIV envelope (Env) proteins has not been
well defined. We found that simian human immunodeficiency virus (SHIV) virus-like particles (VLPs) containing HIV Env
proteins preferentially induce apoptosis of cells corresponding to their coreceptor usage in a CD41 T cell line. We also
demonstrated that induction of apoptosis by SHIV VLPs is correlated with coreceptor usage in a non-T cell line. We examined
the effects of SHIV VLPs containing Env proteins derived from either a T-cell-tropic HIV (BH10) strain or a dual-tropic HIV
(89.6) strain on induction of apoptosis in recombinant CD41 human osteosarcoma (HOS) cells expressing either CXCR4
(HOS-CD4.CXCR4) or CCR5 coreceptors (HOS-CD4.CCR5). HOS-CD4.CXCR4 or HOS-CD4.CCR5 cells were activated with
concanavalin A and cocultured with VLPs. By TUNEL (TdT-mediated dUTP-X nick end labeling) fluorescence staining and flow
cytometry assays, SHIV BH10 VLPs were found to preferentially induce apoptosis in HOS-CD4.CXCR4 cells but not in
HOS-CD4 or HOS-CD4.CCR5 cells. On the other hand, SHIV 89.6 VLPs induced an elevated level of apoptosis in both
HOS-CD4.CXCR4 and HOS-CD4.CCR5 cells in a dose-dependent fashion. These data demonstrate that T-cell-tropic BH10 Env
preferentially utilizes CXCR4, but not CCR5, for induction of apoptosis, whereas dual-tropic 89.6 Env induces apoptosis in
both CXCR4- and CCR5-containing cell lines. © 2001 Academic Press
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The envelope (Env) protein of human immunodefi-
ciency virus (HIV) plays a major role in mediating HIV
entry. Molecular determinants for HIV-1 tropism, as well
as replication efficiency and cytopathicity in infected
cells, are found in the Env protein, particularly within the
V3 loop region of gp120. The V3 region is also an impor-
tant determinant of coreceptor usage (Doms and Peiper,
1997; Rizzuto et al., 1998; Trkola et al., 1996; Wu et al.,
996). HIV infects human T cells and monocytes/macro-
hages by interaction with CD4 and either coreceptor
XCR4 or coreceptor CCR5, which determines the cellu-
ar tropism. Macrophage-tropic (M-tropic) HIV-1 strains
an utilize CD4 and the b-chemokine receptor CCR5 as
heir coreceptor to infect macrophages. The T-cell-tropic
T-tropic) HIV-1 viruses interact with CD4 and the a-che-
okine receptor CXCR4 to enter CD41 T cells, whereas
the dual-tropic HIV viruses may use CD4 and either
CXCR4 or CCR5 to infect T cells and macrophages
(Berger et al., 1999).
One of the characteristics of HIV pathogenesis is a
sustained CD4 helper T cell loss. However, the extent of
1 To whom correspondence and reprint requests should be ad-
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128depletion does not correlate with infection of peripheral
CD41 T cells. The precise cause of this loss of CD41 T
ells is unknown, but a favored hypothesis is that the
irus primes the cell for apoptotic cell death (Ameisen
nd Capron, 1991). An essential determinant of HIV-1-
nduced apoptosis is the expression of the HIV-1 enve-
ope glycoprotein complex (gp120/gp41), which is a po-
ent inducer of apoptosis (Heinkelein et al., 1997; Lau-
ent-Crawford et al., 1993, 1995; Ohnimus et al., 1997,
999). CD41 T cells could be triggered by HIV gp120
inding followed by T cell activation, resulting in activa-
ion-induced apoptosis (Boirivant et al., 1998). The HIV
rotein Tat is also reported to sensitize T cell receptor
TCR) and gp120 activation-induced apoptosis of cells by
n increase in CD95 (Fas) ligand messenger RNA ex-
ression (Bartz and Emerman, 1999; Katsikis et al., 1997;
i et al., 1995; Westendorp et al., 1995).
Apoptosis is an active suicide mechanism and often
esults from incomplete or desynchronized signal trans-
uction related to either the nature of the antigen-pre-
enting cell or the absence of an adequate activation
osignal. It has been proposed that HIV gp120, by inter-
cting with CD4, could partially turn on an activation
ignal in uninfected CD41 T cells. Due to this false
activation, this improper and partial signal would prime
CD41 T cells for apoptosis (Banda et al., 1992; Finco et
al., 1997; Jaworowski and Crowe, 1999; Westendorp et al.,
1995). Productive infection by HIV-1 may not require
signaling through chemokine receptors, but the trans-
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129HIV ENV-INDUCED APOPTOSISductional events together with CD4-dependent signals
may play a role in HIV-1-induced cell death. However, the
influence of HIV Env on other cell types is not clear.
There are recent reports that CXCR4 is involved in HIV-1
gp120-induced neuron and CD81 T cell apoptosis (Her-
ein et al., 1998; Hesselgesser et al., 1998). In another
tudy, purified HIV-1 gp120 showed a significant cyto-
oxic effect on human vascular endothelial cells (Huang
t al., 1999).
In the present study, we have used two different types
f HIV Env proteins incorporated into SHIV virus-like
articles (Yao et al., 2000) to determine whether HIV Env
n virus-like particles (VLPs) could induce apoptosis in a
D41 T cell line and non-T cell lines and whether these
ifferent strains of HIV Env differentially utilize CXCR4
nd CCR5 coreceptors for induction of cell apoptosis. We
ave also determined whether cellular activation using
oncanavalin A (Con A) is required for Env-induced cell
poptosis.
RESULTS
ncorporation of HIV Env proteins in SHIV VLPs
The incorporation of BH10 and 89.6 HIV-1 Env proteins
nto simian human immunodeficiency virus (SHIV) VLPs
as first characterized by using immunoprecipitation.
ltracentrifugation pellets from 35S-labeled baculovirus
recombinant (rBV) SIV gag and rBV HIV env t (Yamsh-
hikov et al., 1995; Yao et al., 2000) coinfected Sf9 cell
culture medium were lysed and immunoprecipitated with
rabbit anti-HIV Env and monkey anti-SIV polyclonal anti-
bodies. Proteins were separated using an 8% SDS–
PAGE. In Fig. 1, lane 1 shows the protein composition of
SHIV 89.6 VLPs and lane 2 shows SHIV BH10 VLPs.
Pr56gag can be readily detected in both types of SHIV
VLPs. Both the Env precursor gp160 and the cleaved
gp120 can be clearly detected in both types of SHIV
VLPs. Coomassie blue staining and Western blot analy-
ses were used to estimate the relative amounts of SIV
Gag and HIV Env in both types of VLPs (data not shown),
and the Env/Gag ratio was found to be about 0.2–0.4.
To further demonstrate that HIV-1 Env is incorporated
in SHIV VLPs rather than present as free Env in VLP
preparations, a series of immunoprecipitations was per-
formed on the ultracentrifugation supernatants and pel-
lets from infected Sf9 cells expressing SHIV proteins.
Since expression of retrovirus gag is sufficient to form
budded virions at the cell surface, we infected Sf9 cells
with rBV gag to obtain SIV Gag particles (SIV Gag VLPs).
We then mixed SIV Gag VLPs with free Env protein (rBV
HIV env t-infected Sf9 cell culture supernatant) to deter-
mine whether the Env protein is associated with SIV Gag
VLPs after ultracentrifugation. However, we could only
detect SIV Gag but no free Env in ultracentrifugation
pellets of the mixture of soluble Env protein with SIV Gag
VLPs (data not shown). This result indicates that the Envdetected in SHIV VLPs is indeed incorporated into VLPs
rather than present as free Env in VLP preparations.
Induction of CEM CD41 T cell apoptosis by SHIV
BH10 VLPs
The TUNEL (TdT-mediated dUTP-X nick end labeling)
assay was used to test whether VLPs would induce
apoptosis in CEM (CD4.CXCR4) T cells. Since Con A can
nonspecifically activate cells, we included Con A in the
incubation period. Cells were cultured in the presence of
Con A and medium alone, purified HIV gp120 protein, or
SHIV BH10 VLPs. Since purified HIV gp120 protein is
reported to induce apoptosis in T cell lines (Radrizzani et
al., 1995; Sunila et al., 1997), it was used as a positive
control in the experiment. Figure 2A is a negative control
using only Con A, which showed only about 1.6% spon-
taneous apoptosis. As shown in Fig. 2B, we observed
that HIV gp120 could induce about 29% of apoptosis in
CEM cells. Interestingly, SHIV BH10 VLPs were found to
induce about 43% apoptosis, as shown in Fig. 2C. There-
fore, the ability of VLPs to induce apoptosis is at least
comparable to that of the purified gp120 proteins. We
have also observed that SHIV BH10 VLPs induce apo-
ptosis in primary CD41 T lymphocytes. Normal human
eripheral blood mononuclear cells (PBMCs) were
ocultured with 50 mg/ml of SHIV BH10 VLPs in the
presence of Con A. Four days postcocultivation, the sub-
1
FIG. 1. Immunoprecipitation of 35S-labeled SHIV 89.6 VLPs and SHIV
H10 VLPs. Lane 1, SHIV 89.6 Envt VLPs, and lane 2, SHIV BH10 Envt
VLPs. Proteins were labeled and immunoprecipitated as described
under Materials and Methods and analyzed by SDS–8% PAGE under
reducing conditions. Rabbit anti-HIV Env and monkey anti-SIV antibod-
ies were used in immunoprecipitation.set of CD4 T cells was labeled by anti-human CD4
antibody conjugated with phychoerythrin (PE), followed
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130 YAO, COMPANS, AND CHENby TUNEL assay. Figure 3A shows PBMCs without VLP
cocultivation and Fig. 3B shows PBMC with VLP cocul-
tivation. We observed that about 33% of primary CD41 T
ells in CD41 T cell subsets underwent apoptosis (Fig.
3B). These results indicate that HIV-1 Env incorporated in
SHIV VLPs is functional in induction of apoptosis in CD41
T cells corresponding to its coreceptor usage.
SHIV BH10 VLPs preferentially enhance
HOS-CD4.CXCR4 cell apoptosis
Although it has been shown that HIV Env glycoproteins
can trigger apoptosis in CD41 cells, whether the core-
eptors play any role in this process has not been clearly
stablished. We used different cell lines that express
lternative coreceptors in combination with CD4 to in-
estigate the effect of SHIV VLPs on those cells. Three
ifferent types of genetically engineered human osteo-
arcoma (HOS) cell lines were used, HOS-CD4, HOS-
FIG. 3. FACS analysis of SHIV BH10 VLP-induced human PBMC
poptosis. CD41 T cell subsets were stained with anti-human CD4-PE.
Apoptotic cells were stained with dUTP-FITC. (A) PBMCs without VLP
FIG. 2. Flow cytometric analysis of CEM cells after treatment with HIV
Con A (10 mg/ml) only (1.6% apoptosis). (B) CEM cells were incubated
CEM cells were incubated with 50 mg/ml SHIV BH10 VLPs and Con A
eagent and analyzed by FACS.treatment. (B) PBMCs incubated with 50 mg/ml SHIV BH10 VLPs and
Con A for 4 days (33% of CD41 T cells exhibit apoptosis).D4.CXCR4, and HOS-CD4.CCR5. Staurosporine is a po-
ent inhibitor of phospholipid/calcium-dependent protein
inase; therefore, it was used as a positive control to
nduce apoptosis. It was found to induce more than 85%
poptosis in the three cell types (Table 1). A negative
ontrol with cells cultured under normal conditions
howed only about 1.3–2.1% apoptosis in the three cell
ypes. When SHIV BH10 VLPs were cocultured with HOS
ells at a final concentration of 100 mg/ml, only 10.3–
12.4% of cells underwent apoptosis in all cell types
tested. When Con A alone was added to the medium,
8.3–9.5% cell apoptosis was observed, which is about a
fourfold increase of apoptosis over that without Con A
stimulation. As we observed for CEM cells, the apoptotic
cell fraction in HOS-CD4.CXCR4 cells increased to 56.8%
when Con A was added to the culture medium together
with 100 mg/ml of SHIV BH10 VLPs (Fig. 4, Table 1). In
contrast, apoptosis in HOS-CD4 or HOS-CD4.CCR5 cells
increased to only 32%. Since SHIV BH10 VLPs, which
contain the T-tropic Env protein, induce substantially
higher levels of apoptosis of cells that contain the cor-
responding CXCR4 coreceptors, the results indicate that
these VLPs preferentially induce apoptosis in cells ex-
pressing CXCR4. Furthermore, these results show that
HIV-1 Env can induce apoptosis not only in T cells but
also in non-T cells that express CD4 receptors and co-
receptors for the HIV-1 Env protein. Since these results
were obtained with a cytoplasmic domain-truncated Env
protein, the results also indicate that this is sufficient to
induce apoptosis, and the full-length cytoplasmic domain
is not necessary for induction of apoptosis by HIV Env. To
further determine whether CD4 is necessary for SHIV
VLP-induced apoptosis, we cocultivated SHIV BH10
VLPs with HOS-CXCR4 cells in the presence of Con A
under the same conditions as described previously.
or SHIV BH10 VLPs. (A) Negative control. CEM cells were treated with
mg/ml purified HIV gp120 and Con A for 4 days (28.7% apoptosis). (C)
ays (42.8% apoptosis). After treatment, cells were stained with TUNELgp120
with 10About 31% apoptosis was observed in cells bearing only
coreceptors, but not CD4 receptors, with SHIV VLP treat-
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131HIV ENV-INDUCED APOPTOSISment (data not shown). These data indicate that both
receptor CD4 and coreceptor CXCR4 are important in
SHIV BH10 VLP-induced apoptosis.
SIV Gag VLPs, which lack the HIV Env, were used as
a control to determine whether the Env function is es-
sential in apoptosis. When cells were cultured with 50
mg/ml of SIV Gag VLPs, only background levels of apo-
ptosis were observed in all three cell types (Table 1).
Furthermore, no increase in apoptosis was observed
when the concentration of Gag VLPs was increased to
100 mg/ml in the Gag VLPs 1 Con A control. These
esults indicate that the observed apoptosis is depen-
ent upon the presence of Env in the SHIV BH10 VLPs,
nd that VLPs containing only Gag are not sufficient for
nducing apoptosis.
Apoptosis induced by SHIV VLPs was found to be
ose-dependent. The percentage of apoptotic cells in-
reased progressively in all three cell types when in-
reasing amounts of SHIV VLPs were added into the
ulture media. In HOS-CD4.CXCR4 cells (Table 1), the
ercentages of apoptosis were 29.1, 43.1, and 56.8% when
HIV BH10 VLP concentrations were 50, 75, and 100
mg/ml, respectively. In contrast, no dose-dependent in-
crease of apoptosis was observed in SIV Gag VLP-
treated cells.
To further compare apoptosis induced by SHIV BH10
VLPs in the three different cell types, we completed
FACS analysis via the TUNEL assay (Fig. 5). SHIV BH10
VLPs induced only a small percentage of apoptotic cells
in the three cell types, but with the addition of Con A
there was an increase to 54% in CXCR4 coreceptor
TABLE 1
Effect of SHIV BH10 VLPs on Human Osteosarcoma
Cell (HOS) Apoptosis
HOS-CD4 HOS-CD4.CXCR4 HOS-CD4.CCR5
Culture media (2) 2.1 6 0.9a 1.3 6 0.6 1.6 6 0.5
Staurosporineb (1) 89.4 6 8.3 87.3 6 9.6 84.5 6 10.1
Con Ac 8.6 6 3.4 9.5 6 2.7 8.3 6 2.8
BH10 VLP
(100 mg/ml)
10.3 6 3.8 11.5 6 4.6 12.4 6 4.6
BH10 VLP 1 Con A
(50 mg/ml)
18.4 6 6.2 29.1 6 9.3 17.4 6 5.5
BH10 VLP 1 Con A
(75 mg/ml)
24.1 6 8.4 43.1 6 8.6 25.3 6 9.1
BH10 VLP 1 Con A
(100 mg/ml)
31.5 6 9.5 56.8 6 10.3 32.1 6 8.3
Gag VLP 1 Con A
(50 mg/ml)
13.1 6 3.5 12.3 6 4.2 11.6 6 4.5
a Percentage of apoptotic cells counted in an average of eight dif-
erent fields in TUNEL fluorescence slides 6 SD.
b Staurosporine (1 mM) was used as a positive control.
c A quantity of 10 mg/ml was used for all concanavalin A-containing
xperiments.bearing cells, but not in the other two cell types. These
results further support the conclusion that Env on theSHIV BH10 VLPs preferentially uses CXCR4 as corecep-
tor for enhanced cell apoptosis.
SHIV 89.6 VLPs induce apoptosis in both
HOS-CD4.CXCR4 and HOS-CD4.CCR5 cells
To further determine whether the usage of coreceptors
by HIV Env is correlated with VLP-induced apoptosis, we
compared the ability of SHIV 89.6 VLPs, which contain a
dual-tropic Env protein, to that of SHIV BH10 VLPs. The
TUNEL staining of apoptotic cells induced by SHIV 89.6
VLPs in different HOS cell types is shown in Fig. 6, and
the FACS analysis of apoptotic cells is shown in Fig. 7. A
positive control with staurosporine showed more than
85% apoptosis. Negative and Con A incubation controls
showed low levels of apoptosis. However, we observed
enhanced (58%) induction of apoptosis with SHIV 89.6
VLPs in the presence of Con A in both HOS-CD4.CXCR4
and HOS-CD4.CCR5 cells (Table 2). Furthermore, SHIV
89.6 VLPs enhanced apoptosis in a dose-dependent
manner from about 30% at a dose of 50 mg/ml to about
60% at 100 mg/ml. These data demonstrate that SHIV
89.6 VLPs are able to use both CXCR4 and CCR5 core-
ceptors for induction of apoptosis.
Blocking of VLP-induced apoptosis by antibodies
against coreceptors
To further study whether the Env–coreceptor interac-
tion is required in VLP-induced apoptosis, a blocking
FIG. 4. SHIV BH10 VLP-induced HOS cell apoptosis (TUNEL fluores-
cence microscopy). (A) HOS-CD4.CXCR4 without SHIV VLP treatment
(1.3 6 0.6% apoptosis). (B) HOS-CD4 with SHIV VLPs (100 mg/ml)
treatment (31.5 6 9.5% apoptosis). (C) HOS-CD4.CXCR4 with SHIV VLP
(100 mg/ml) treatment (56.8 6 10.3% apoptosis). (D) HOS-CD4.CCR5
with SHIV VLP (100 mg/ml) treatment (32.1 6 8.3% apoptosis).
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132 YAO, COMPANS, AND CHENassay was performed by using monoclonal antibody
against CXCR4 (12G5). CEM cells were preincubated
with 12G5 at 10 mg/ml for 2 h and then adsorbed with
FIG. 5. Effect of SHIV BH10 VLPs on human osteosarcoma cell apopt
3.5%); VLP treatment (12.6%); and VLP 1 Con A treatment (27.5%). (B
(24.1%); and VLP 1 Con A treatment (53.7%). (C) HOS-CD4.CCR5 and
A treatment (27.5%).
FIG. 6. SHIV 89.6 VLP-induced HOS cell apoptosis (TUNEL fluores-
cence microscopy). (A) HOS-CD4.CCR5 without SHIV VLP treatment
(1.6 6 0.5% apoptosis). (B) HOS-CD4 with SHIV VLP (100 mg/ml) treat-
ment (34.1 6 8.9% apoptosis). (C) HOS-CD4.CXCR4 with SHIV VLP (100m
e
mg/ml) treatment (57.8 6 10.6% apoptosis). (D) HOS-CD4.CCR5 with
SHIV VLP (100 mg/ml) treatment (58.3 6 10.5% apoptosis).HIV BH10 VLPs for 16 h prior to Con A stimulation. Four
ays postcocultivation, a TUNEL assay was performed to
ompare the apoptosis in different treatments. Figure 8A
hows the negative control of CEM cells at only 0.5%
poptosis. Figure 8B is the cocultivation of SHIV BH10
LPs plus Con A, showing 53% apoptosis. Figure 8C
hows preincubation of cells with monoclonal antibody
gainst CXCR4 (12G5) and then cocultivation with SHIV
H10 VLPs plus Con A leading to 29% apoptosis. Similar
poptotic inhibition results were also obtained with a
onoclonal antibody against CCR5 (2D7) in HOS-CD4-
CR5 cell lines with cocultivation of SHIV 89.6 VLPs
data not shown). These results further indicate that the
nteraction between Env and its corresponding corecep-
ors is involved in induction of apoptosis.
DISCUSSION
We have demonstrated that HIV Env proteins can dif-
erentially utilize CCR5 or CXCR4 coreceptors for induc-
ion of apoptosis in both T cell lines as well as non-T cell
ines. The coreceptor CXCR4 preferentially promotes
H10 VLP-induced apoptosis, while both CXCR4 and
CR5 potentiate dual-tropic HIV-1 89.6 VLP-induced ap-
ptosis in a dose-dependent fashion. Addition of the
itogen Con A greatly enhances both T-cell-tropic and
ual-tropic SHIV VLP-induced apoptosis. Furthermore,
his apoptosis is induced by VLPs in a dose-dependent
NEL flow cytometry). (A) HOS-CD4 and three groups: negative control
CD4.CXCR4 and three groups: negative control (5.1%); VLP treatment
roups: negative control (4.7%); VLP treatment (18.8%); and VLP 1 Conosis (TU
) HOS-anner. We have previously demonstrated that HIV Env
xpressed on the insect cell surface could induce CD41
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biologically functional (Yao et al., 2000). We found in this
study that Env incorporated into VLPs can induce apo-
ptosis in both T cell and non-T cell lines. Although some
reports have indicated that monomeric gp120 can prime
apoptosis in uninfected cells by cross-linking with anti-
gp120 antibodies (Banda et al., 1992; Oyaizu et al., 1997),
nother study reported that apoptosis induced by recom-
FIG. 7. Effect of SHIV 89.6 VLPs on human osteosarcoma cell apopto
(3.5%); VLP treatment (20.9%); and VLP 1 Con A treatment (25.7%). (B
(23.7%); and VLPs 1 Con A treatment (65.4%). (C) HOS-CD4.CCR5 and
A treatment (62.4%).
TABLE 2
Effect of SHIV 89.6 VLPs on HOS Cell Apoptosis
HOS-CD4 HOS-CD4.CXCR4 HOS-CD4.CCR5
Culture media (2) 2.1 6 0.9a 1.3 6 0.6 1.6 6 0.5
Staurosporineb (1) 89.4 6 8.3 87.3 6 9.6 84.5 6 10.1
Con Ac 8.6 6 3.4 9.5 6 2.7 8.3 6 2.8
89.6 VLP
(100 mg/ml)
11.4 6 2.9 10.5 6 3.9 13.3 6 5.1
89.6 VLP 1 Con A
(50 mg/ml)
16.9 6 5.3 26.3 6 8.2 28.7 6 6.5
89.6 VLP 1 Con A
(75 mg/ml)
27.3 6 9.2 47.9 6 7.3 44.6 6 9.6
89.6 VLP 1 Con A
(100 mg/ml)
34.1 6 8.9 57.8 6 10.6 58.3 6 10.5
ag VLP 1 Con A
(50 mg/ml)
13.1 6 3.5 12.3 6 4.2 11.6 6 4.5
a Percentage of apoptotic cells counted in an average of eight dif-
erent fields in TUNEL fluorescence slides 6SD.
b Staurosporine (1 mM) was used as a positive control.
c A quantity of 10 mg/ml was used for all concanavalin A-containing
xperiments.inant gp120 was not as efficient as that by protease-
efective virus particles (Kameoka et al., 1997). Kameoka
et al. (1997) reported that a protease-defective gp120-
containing HIV-1 particle induced apoptosis more effi-
ciently than wild-type (wt) LAI virus or recombinant
gp120. One explanation for this phenomenon is the
greater amount of surface gp120 incorporated into these
particles than into wt LAI particles, since they reported a
relative ratio of Env/Gag of 0.8 in these particles but only
of 0.2 in wt LAI particles. Recently, conformationally au-
thentic noninfectious HIV-1 particles were reported to
enhance apoptosis in CD41 T cells compared with re-
combinant gp120 (Esser et al., 2001). We found that
ytoplasmic domain truncations in the Env glycoprotein
ed to much higher levels of Env in the VLPs than are
resent in wild-type virions (Yao et al., 2000). The relative
atio of Env/Gag was about 0.2–0.4 in SHIV particles. In
ccord with previous findings, we also found that Env in
LPs induces higher levels of apoptosis than purified
p120. A high level of apoptosis was readily seen in
OS-CD4 cells using SHIV BH10 VLPs 1 Con A or 89.6
VLPs 1 Con A. This may be because of more efficient
binding of CD4 with native Env in VLPs than with recom-
binant gp120. The Env incorporated in VLPs may also
exhibit a higher capacity for cross-linking receptors than
soluble gp120. The amount of VLPs required to induce
significant levels of apoptosis is higher than the virion
levels found in the plasma of infected individuals, and
NEL flow cytometry). (A) HOS-CD4 and three groups: negative control
CD4.CXCR4 and three groups: negative control (5.1%); VLP treatment
roups: negative control (4.9%), VLP treatment (22.1%); and VLP 1 Consis (TU
) HOS-this is also the case with apoptosis induced by recom-
binant gp120.
ted wit
134 YAO, COMPANS, AND CHENEarly studies reported that apoptosis occurred only
with infectious HIV-1, implying that cell surface binding
and signaling by the virus alone were insufficient to
trigger apoptosis (Corbeil and Richman, 1995; Terai et al.,
1991). However, more recent data have shown that CD41
T cells die by apoptosis upon contact with Env-express-
ing cells independent of viral replication (Blanco et al.,
1999; Maldarelli et al., 1995). Moreover, studies of induc-
tion of apoptosis by Sindbis virus indicated that this
process occurred at cell entry and that virus replication
was not needed (Jan and Griffin, 1999). It has been
reported that HIV-1 gp120 cross-linked by anti-gp120
antibodies induced apoptosis in infected or noninfected
T lymphocytes (Laurent-Crawford et al., 1993; Westen-
dorp et al., 1995; Banda et al., 1992), and it has been
suggested that enhanced expression of CD95L leads to
CD95-mediated apoptosis (Westendorp et al., 1995).
Moreover, some groups have reported caspase-indepen-
dent activation-induced cell death (Lesage et al., 1997;
Skov et al., 1997), suggesting the existence of another
death-inducing system besides CD95-mediated apopto-
sis. A study of the effect of HIV-1 Env on endothelial cells
suggests that gp120 upregulates expression of both
macrophage-bound tumor necrosis factor-a and CD81
T-cell-bound TNF receptor II, and that apoptosis is me-
diated by the interaction between these two factors
(Huang et al., 1999). Our results together with those of
others support the hypothesis that interaction between
cell surface Env and its receptors triggers apoptosis of
the cell. The induction of apoptosis can be considered as
a factor that contributes, at least in part, to CD41 cell
depletion (Pantaleo and Fauci, 1995).
The lectin Con A has been used extensively as a
T-cell-specific mitogen (Sharon, 1983). However, the ex-
act mechanism of Con A-induced T cell activation has
not been defined. It is thought to exert its mitogenic
effect on T cells by cross-linking TCR and/or associated
proteins. Con A has multiple binding sites for a-D-man-
nose and has been shown to bind to a number of mem-
brane proteins, including Thy-1, MHC class I and class II
FIG. 8. Effect of 12G5 on apoptosis induced by SHIV BH10 VLPs. (A) N
with VLPs 1 Con A, showing 53% apoptosis; (C) CEM cells preincuba
apoptosis. Four days postcocultivation, TUNEL assay was performed.products, and TCR (Marchalonis, 1987; Weiss et al.,
1987). A wide variety of mitogens have been used in vitroto dissect the components of T cell activation (Lis and
Sharon, 1987). We found that Con A stimulation contrib-
utes significantly to the induction of apoptosis by VLPs
and that there is no evident specificity for the presence of
coreceptors on the cells in the absence of Con A stim-
ulation. Con A stimulation alone in the absence of VLPs
increased apoptosis by approximately fourfold over that
with no Con A stimulation. This may be due to the
extensive binding activity of Con A to numerous cell
surface glycoproteins that transduce stimuli into the cell;
it is likely that some of these stimuli cause expression or
activation of proteins required to activate the apoptotic
process in cells. Since there is a possibility that Con A
can bind to gp120, we added VLPs 1 day before to
ensure establishment of specific binding of Env with its
receptor and coreceptors and then added Con A to
stimulate cells. In this way, we minimized the possible
effect of Con A and gp120 interaction on Env–coreceptor
interactions and induction of apoptosis. Other studies
with protease-defective gp120-containing particles
showed a significant level (40–50%) of apoptosis in
healthy donor-derived PBMC-Ts after subsequent mito-
genic stimulation with PHA, Con A, or ionomycin (Ka-
meoka et al., 1997).
HOS cells are genetically engineered human osteo-
sarcoma cell lines that express CD4 and either CXCR4 or
CCR5. Although they are non-T cells lines, we found that
they are susceptible to apoptosis induced by VLPs con-
taining biologically functional Env. Our results show that
a large percentage of HOS-CD4 and HOS-CD4.CCR5
cells undergo apoptotic changes following exposure to
the SHIV BH10 VLPs and Con A. Likewise, a large per-
centage of HOS-CD4 cells exhibits apoptotic changes
after exposure to SHIV 89.6 VLPs and Con A. There are
multiple levels of Env–cell interactions that can contrib-
ute to cell death, as discussed above. CD4-dependent
signals may play a major role in HIV-1-induced cell
death, and although productive infection by HIV-1 does
not require signaling through chemokine receptors,
these transductional events together with CD4-depen-
control without VLPs, showing 0.5% apoptosis; (B) CEM cell coculture
h 12G5 for 2 h and then cocultured with VLPs 1 Con A, showing 29%egativedent signals may contribute to apoptosis. Indeed, CXCR4
has been reported to be involved in gp120-induced neu-
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135HIV ENV-INDUCED APOPTOSISron and CD8 apoptosis (Herbein et al., 1998; Hessel-
gesser et al., 1998). However, the role of CXCR4 in cell
surface-expressed HIV-1 envelope protein-induced apo-
ptosis in CD4 cells has not been well defined. Our
findings suggest that the Env–coreceptor interaction is
important in apoptosis induction, since blocking of this
interaction by monoclonal antibodies can partially inhibit
apoptosis. Furthermore, previous studies have shown
that the CD4 binding domain in gp120 is important for
triggering apoptosis in CD41 T cells (Esser et al., 2001;
LaBranche et al., 1999). Our data suggests that there may
be a difference in signaling when Env binds to CD4
versus when gp120 binds with CD4 plus coreceptors.
Higher affinity binding of Env to cells expressing CD4
and coreceptors may contribute to the greater population
of the cells that receive a death signal from a cell surface
binding event. Since there are free infectious and non-
infectious virus particles and free HIV-1 proteins circu-
lating within the host during the course of an HIV-1
infection, those extracellular HIV-1 Env proteins could
influence cell function, leading to disease pathogenesis.
MATERIALS AND METHODS
Cells, proteins, and antibodies
Recombinant human osteosarcoma cells bearing CD4,
CD4.CXCR4, or CD4.CCR5 were obtained from the NIH
AIDS Research and Reference Reagent Program (Deng
et al., 1996; Landau and Littman et al., 1992). All HOS
cells were maintained in DMEM with 10% fetal calf se-
rum (FCS) at 37°C with 5% CO2. The CEM T cell line,
which expresses both CD4 and CXCR4, was cultured in
RPMI supplemented with 10% FCS, penicillin G (100
U/ml), and streptomycin (100 mg/ml). Purified HIV gp120
IIIB) was purchased from Intracel (Cambridge, MA) and
econstituted in deionized water. Monoclonal antibodies
mouse) to fusin (12G5) and to CCR5 (2D7) were obtained
rom the NIH AIDS Research and Reference Reagent
rogram (Endres et al., 1996; Wu et al., 1997). Antibody to
uman CD4 conjugated with PE was purchased from
harMingen (San Diego, CA).
roduction of SHIV VLPs
SHIV BH10 VLPs and SHIV 89.6 VLPs were produced
s previously described (Yao et al., 2000). Briefly, Sf9
nsect cells were coinfected with a baculovirus recom-
inant expressing SIV gag at a m.o.i. of 1 and rBV ex-
ressing HIV env t (a cytoplasmic domain truncation mu-
tant of Env) at a m.o.i. of 5. For SIV Gag VLPs, Sf9 cells
were infected only with rBV SIV gag at a m.o.i. of 1. At 4
ays postinfection, the culture media were collected and
entrifuged at 2500 rpm for 20 min (Beckman GPR desk-
op centrifuge, Beckman Instruments, Fullerton, CA). The
upernatant was then filtered through a 0.45-mM filter
nd VLPs were pelleted at 120,000g for 2 h at 4°C. The
tresuspended VLPs were then purified through a 20–60%
continuous sucrose gradient at 100,000g for 16 h at 4°C.
The VLP band was collected and dialyzed against PBS in
a 10,000 MW cut-off membrane. Pelleted VLPs were then
resuspended overnight in PBS. Western blot analysis
was utilized to determine Env incorporation into the VLPs
by using polyclonal rabbit anti-HIV Env antibodies ob-
tained from Dr. Harriet Robinson (Yerkes Primate Re-
search Center, Emory University, Atlanta, GA). Coomas-
sie blue staining was used to determine the total protein
profile of VLPs. The total protein concentration of VLPs
was determined by a Bio-Rad (Richmond, CA) protein
assay. For experiments, the protein content in all VLPs
was adjusted to 2 mg/ml.
Analysis of VLP-associated SIV and HIV proteins
To determine SHIV VLP protein composition and ana-
lyze the incorporation of HIV Env protein in SHIV VLPs,
immunoprecipitation of metabolically labeled superna-
tants of the infected Sf9 cells was performed, followed by
SDS–PAGE. Briefly, Sf9 cells were coinfected with rBV
SIV gag at a multiplicity of infection (m.o.i.) of 5 and rBV
IV 89.6 env t or rBV BH10 env t at an m.o.i. of 10. At 24 h
postinfection, cells were continuously labeled for 24 h
with 50 mCi of [35S]methionine and cysteine per milliliter
in a mixture of 75% met-deficient and 25% complete
medium. Supernatants were collected and pelleted at
120,000g for 1 h at 4°C. Pellets were then lysed with RIPA
buffer [150 mM NaCl, 50 mM Tris–HCl (pH 7.5)], 1% Triton
X-100, 1% SDS, 1 mM EDTA, protease inhibitor cocktail
tablet purchased from Roche Molecular Biochemicals,
Indianapolis, IN] and immunoprecipitated with monkey
anti-SIV polyclonal antibody and rabbit anti-HIV Env poly-
clonal antibody at 4°C for 2 h, followed by protein A
overnight. Samples were washed three times in RIPA
buffer followed with 25 mM Tris, pH 6.8, and analyzed by
SDS–PAGE. Each band of either Env gp120 or the Gag
protein visualized on the X-ray film was scanned and
quantified by a NIH image program. A relative ratio of
Env gp120/Gag protein (Env/Gag) was calculated for
each type of VLP.
Induction of apoptosis by SHIV VLPs
CEM T cells or HOS-CD4, HOS-CD4.CXCR4, and HOS-
CD4.CCR5 cells were incubated in 10% FCS with SHIV
VLPs at a final concentration of 50–100 mg/ml of total
rotein at 37°C for 18 h. Concanavalin A at a final
oncentration of 10 mg/ml was then added to the culture
edium for 3 more days. A Con A-only control was
arried out with cells cultured in the medium with the
ddition of 10 mg/ml Con A and without the addition of
LPs. As a positive control, staurosporine at a concen-ration of 1 mM was added at the third day of cell culture.
As an Env-deficient VLP control, SIV Gag VLPs without
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136 YAO, COMPANS, AND CHENHIV envelope proteins were used at a final concentration
of 50 mg/ml.
easurement of apoptosis
Apoptotic cells were measured by using a TUNEL
ssay kit from Roche Molecular Biochemicals. One
ethod was used for adherent cells, which were grown
n coverslips. After 4 days of treatment with VLPs, cells
ere washed two times with PBS/1% BSA. Cells were
irst fixed with 4% freshly prepared formaldehyde for 30
in at room temperature and then permeabilized in per-
eabilization solution (0.1% Triton X-100 in 0.1% sodium
itrate) for 2 min at 4°C. After washing, cells were
tained with the TUNEL reaction mixture at 37°C for 60
in. The cells were observed under a fluorescence mi-
roscope after extensive washing. Only those cells that
nderwent apoptosis had bright fluorescent staining in
heir nuclei. The percentage of apoptotic cells was
ounted under a high-power objective lens (345) and a
inimum of eight different fields was included in each
lide.
Another method was to use a TUNEL assay to analyze
poptotic cells by flow cytometry (FACS). Briefly, after 4
ays of treatment with the VLPs, cells were trypsinized
nd washed 2 times with PBS/1% BSA. Cells were then
djusted to 2 3 107 cells/ml, and 100 ml of cell suspen-
ion was added into a V-bottom 96-well tissue culture
late. Cells were first fixed with 4% freshly prepared
ormaldehyde for 30 min at room temperature, and then
ells were permeabilized in permeabilization solution
0.1% Triton X-100 in 0.1% sodium citrate) for 2 min at 4°C.
fter washing, cells were stained with 50 ml of TUNEL
eaction mixture at 37°C for 60 min. Cells were then
ashed 2 more times and resuspended in 200 ml of PBS
for FACS analysis.
ACKNOWLEDGMENTS
This study was supported by NIH/NIAID Grants AI 42691 and AI
42847 and NIH/NHLBI Grant HL 61943. The following reagents were
obtained through the AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH, from Dr. Nathaniel Landau: HOS-CD4,
HOS-CD4.CXCR4, and HOS-CD4.CCR5. CXCR4 monoclonal antibody
(12G5) was obtained from Dr. James Hoxie. CCR5 monoclonal antibody
(2D7) was received from Millennium Pharmaceuticals, Inc., and Phar-
Mingen.
REFERENCES
Ameisen, J. C., and Capron, A. (1991). Cell dysfunction and depletion in
AIDS: The programmed cell death hypothesis. Immunol. Today 12,
102–105.
anda, N. K., Bernier, J., Kurahara, D. K., Kurrle, R., Haigwood, N.,
Sekaly, R. P., and Finkel, T. H. (1992). Crosslinking CD4 by human
immunodeficiency virus gp120 primes T cells for activation-induced
apoptosis. J. Exp. Med. 176, 1099–1106.
artz, S. R., and Emerman, M. (1999). Human immunodeficiency virus
type 1 Tat induces apoptosis and increases sensitivity to apoptotic
signals by up-regulating FLICE/caspase-8. J. Virol. 73, 1956–1963.erger, E. A., Murphy, P. M., and Farber, J. M. (1999). Chemokine
receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and
disease. Annu. Rev. Immunol. 17, 657–700.
lanco, J., Jacotot, E., Cabrera, C., Cardona, A., Clotet, B., De Clercq, E.,
and Este, J. A. (1999). The implication of the chemokine receptor
CXCR4 in HIV-1 envelope protein-induced apoptosis is independent
of the G protein-mediated signaling. AIDS 13, 909–917.
Boirivant, M., Viora, M., Giordani, L., Luzzati, A. L., Pronio, A. M.,
Montesani, C., and Pugliese, O. (1998). HIV-1 gp120 accelerates
Fas-mediated activation-induced human lamina propria T cell apo-
ptosis. J. Clin. Immunol. 18, 39–47.
Corbeil, J., and Richman, D. D. (1995). Productive infection and subse-
quent interaction of CD4-gp120 at the cellular membrane is required
for HIV-induced apoptosis of CD41 T cells. J. Gen. Virol. 76, 681–690.
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di
Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper,
S. C., Schall, T. J., Littman, D. R., and Landau, N. R. (1996). Identifi-
cation of a major co-receptor for primary isolates of HIV-1. Nature
381, 661–666.
Doms, R. W., and Peiper, S. C. (1997). Unwelcomed guests with master
keys: How HIV uses chemokine receptors for cellular entry. Virology
235, 179–190.
Endres, M. J., Clapham, P. R., Marsh, M., Ahuja, M., Turner, J. D.,
McKnight, A., Thomas, J. F., Stoebenau-Haggarty, B., Choe, S., Vance,
P. J., Wells, T. N., Power, C. A., Sutterwala, S. S., Doms, R. W., Landau,
N. R., and Hoxie, J. A. (1996). CD4-independent infection by HIV-2 is
mediated by fusin/CXCR4. Cell 87, 745–756.
Esser, M. T., Bess, J. W., Suryanarayana, K., Chertova, E., Marti, D.,
Carrington, M., Arthur, L. O., and Lifson, J. D. (2001). Partial activation
and induction of apoptosis in CD4(1) and CD8(1) T lymphocytes by
conformationally authentic noninfectious human immunodeficiency
virus type 1. J. Virol. 75, 1152–1164.
inco, O., Nuti, S., De Magistris, M. T., Mangiavacchi, L., Aiuti, A., Forte,
P., Fantoni, A., van der Putten, H., and Abrignani, S. (1997). Induction
of CD41 T cell depletion in mice doubly transgenic for HIV gp120 and
human CD4. Eur. J. Immunol. 27, 1319–1324.
einkelein, M., Muller, M., Kutsch, O., Sopper, S., and Jassoy, C. (1997).
Rapid and selective depletion of CD41 T lymphocytes and preferen-
tial loss of memory cells on interaction of mononuclear cells with
HIV-1 glycoprotein-expressing cells. J. Acquired Immune Defic.
Syndr. Hum. Retrovirol. 16, 74–82.
Herbein, G., Mahlknecht, U., Batliwalla, F., Gregersen, P., Pappas, T.,
Butler, J., O’Brien, W. A., and Verdin, E. (1998). Apoptosis of CD81 T
cells is mediated by macrophages through interaction of HIV gp120
with chemokine receptor CXCR4. Nature 395, 189–194.
Hesselgesser, J., Taub, D., Baskar, P., Greenberg, M., Hoxie, J., Kolson,
D. L., and Horuk, R. (1998). Neuronal apoptosis induced by HIV-1
gp120 and the chemokine SDF-1 alpha is mediated by the chemo-
kine receptor CXCR4. Curr. Biol. 8, 595–598.
Huang, M., Hunter, M., and Bond, V. C. (1999). Effect of extracellular
human immunodeficiency virus type 1 glycoprotein 120 on primary
human vascular endothelial cell cultures. AIDS Res. Hum. Retrovi-
ruses 15, 1265–1277.
Jan, J. T., and Griffin, D. E. (1999). Induction of apoptosis by Sindbis virus
occurs at cell entry and does not require virus replication. J. Virol. 73,
10296–10302.
Jaworowski, A., and Crowe, S. M. (1999). Does HIV cause depletion of
CD41 T cells in vivo by the induction of apoptosis? Immunol. Cell
Biol. 77, 90–98.
Kameoka, M., Kimura, T., Zheng, Y. H., Suzuki, S., Fujinaga, K., Luftig,
R. B., and Ikuta, K. (1997). Protease-defective, gp120-containing hu-
man immunodeficiency virus type 1 particles induce apoptosis more
efficiently than does wild-type virus or recombinant gp120 protein in
healthy donor-derived peripheral blood T cells. J. Clin. Microbiol. 35,
41–47.Katsikis, P. D., Garcia-Ojeda, M. E., Torres-Roca, J. F., Greenwald, D. R.,
Herzenberg, L. A., and Herzenberg, L. A. (1997). HIV type 1 Tat protein
L137HIV ENV-INDUCED APOPTOSISenhances activation—but not Fas (CD95)—induced peripheral
blood T cell apoptosis in healthy individuals. Int. Immunol. 9, 835–
841.
LaBranche, C. C., Hoffman, T. L., Romano, J., Haggarty, B. S., Edwards,
T. G., Matthews, T. J., Doms, R. W., and Hoxie, J. A. (1999). Determi-
nants of CD4 independence for a human immunodeficiency virus
type 1 variant map outside regions required for coreceptor specific-
ity. J. Virol. 73, 10310–10319.
Landau, N. L., and Littman, D. R. (1992). Packaging system for rapid
production of murine leukemia virus vectors with variable tropism.
J. Virol. 66, 5110–5113.
Laurent-Crawford, A. G., Krust, B., Riviere, Y., Desgranges, C., Muller, S.,
Kieny, M. P., Dauguet, C., and Hovanessian, A. G. (1993). Membrane
expression of HIV envelope glycoproteins triggers apoptosis in CD4
cells. AIDS Res. Hum. Retroviruses 9, 761–773.
Laurent-Crawford, A. G., Coccia, E., Krust, B., and Hovanessian, A. G.
(1995). Membrane-expressed HIV envelope glycoprotein het-
erodimer is a powerful inducer of cell death in uninfected CD41
target cells. Res. Virol. 146, 5–17.
esage, S., Steff, A. M., Philippoussis, F., Page, M., Trop, S., Mateo, V.,
and Hugo, P. (1997). CD41 CD81 thymocytes are preferentially in-
duced to die following CD45 cross-linking, through a novel apoptotic
pathway. J. Immunol. 159, 4762–4771.
Li, C. J., Friedman, D. J., Wang, C., Metelev, V., and Pardee, A. B. (1995).
Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat pro-
tein. Science 268, 429–431.
Lis, H., and Sharon, N. (1987). Erythrina lectins. Methods Enzymol. 138,
544–551.
Maldarelli, F., Sato, H., Berthold, E., Orenstein, J., and Martin, M. A.
(1995). Rapid induction of apoptosis by cell-to-cell transmission of
human immunodeficiency virus type 1. J. Virol. 69, 6457–6465.
Marchalonis, J. J. (1987). Lectins in the isolation of receptors on lym-
phocytes. Methods Enzymol. 150, 463–477.
Ohnimus, H., Heinkelein, M., and Jassoy, C. (1997). Apoptotic cell death
upon contact of CD41 T lymphocytes with HIV glycoprotein-express-
ing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1)
and TNF receptor 1. J. Immunol. 159, 5246–5252.
Ohnimus, H., Heinkelein, M., Heeney, J. L., Walker, C. M., and Jassoy, C.
(1999). Lysis of HIV envelope glycoprotein-expressing cells by CD41
T lymphocytes from chimpanzees. J. Acquired Immune Defic. Syndr.
Hum. Retrovirol. 20, 207–213.
Oyaizu, N., Adachi, Y., Hashimoto, F., McCloskey, T. W., Hosaka, N.,
Kayagaki, N., Yagita, H., and Pahwa, S. (1997). Monocytes express
Fas ligand upon CD4 cross-linking and induce CD41 T cells apopto-
sis: A possible mechanism of bystander cell death in HIV infection.
J. Immunol. 158, 2456–2463.
Pantaleo, G., and Fauci, A. (1995). Apoptosis in HIV infection. Nat. Med.
1, 118–120.
Radrizzani, M., Accornero, P., Amidei, A., Aiello, A., Delia, D., Kurrle, R.,and Colombo, M. P. (1995). IL-12 inhibits apoptosis induced in a
human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activa-
tion or by IL-2 deprivation. Cell. Immunol. 161, 14–21.
Rizzuto, C. D., Wyatt, R., Hernandez-Ramos, N., Sun, Y., Kwong, P. D.,
Hendrickson, W. A., and Sodroski, J. (1998). A conserved HIV gp120
glycoprotein structure involved in chemokine receptor binding. Sci-
ence 280, 1949–1953.
Sharon, N. (1983). Lectin receptors as lymphocyte surface markers.
Adv. Immunol. 34, 213–298.
Skov, S., Klausen, P., and Claesson, M. H. (1997). Ligation of major
histocompatability complex (MHC) class I molecules on human T
cells induces cell death through PI-3 kinase-induced c-Jun NH2-
terminal kinase activity: A novel apoptotic pathway distinct from
Fas-induced apoptosis. J. Cell Biol. 139, 1523–1531.
Sunila, I., Vaccarezza, M., Pantaleo, G., Fauci, A. S., and Orenstein, J. M.
(1997). gp120 is present on the plasma membrane of apoptotic CD4
cells prepared from lymph nodes of HIV-1-infected individuals: An
immunoelectron microscopic study. AIDS 11, 27–32.
Terai, C., Kornbluth, R. S., Pauza, C. D., Richman, D. D., and Carson,
D. A. (1991). Apoptosis as a mechanism of cell death in cultured T
lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87, 1710–
1715.
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P.,
Cheng-Mayer, C., Robinson, J., Maddon, P. J., and Moore, J. P. (1996).
CD4-dependent, antibody-sensitive interactions between HIV-1 and
its co-receptor CCR-5. Nature 384, 184–187.
Weiss, A., Shields, R., Newton, M., Manger, B., and Imboden, J. (1987).
Ligand–receptor interactions required for commitment to the activa-
tion of the interleukin 2 gene. J. Immunol. 138, 2169–2176.
Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J.,
Walczak, H., Debatin, K. M., and Krammer, P. H. (1995). Sensitization
of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
Nature 375, 497–500.
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti,
A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, C., and So-
droski, J. (1996). CD4-induced interaction of primary HIV-1 gp120
glycoproteins with the chemokine receptor CCR-5. Nature 384, 179–
183.
Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N.,
Choe, H., Sodroski, J., Newman, W., Koup, R. A., and Mackay, C. R.
(1997). CCR5 levels and expression pattern correlate with infectabil-
ity by macrophage-tropic HIV-1, in vitro. J. Exp. Med. 185, 1681–1691.
Yamshchikov, G. V., Ritter, G. D., Vey, M., and Compans, R. W. (1995).
Assembly of SIV virus-like particles containing envelope proteins
using a baculovirus expression system. Virology 214, 50–58.
Yao, Q., Kuhlmann, F. M., Eller, R., Compans, R. W., and Chen, C. (2000).
Production and characterization of simian–human immunodeficiency
virus-like particles. AIDS Res. Hum. Retroviruses 16, 227–236.
